<DOC>
	<DOCNO>NCT00765752</DOCNO>
	<brief_summary>Disturbances amino acid neurotransmitter ( AANt ) , gamma-amino butyric acid ( GABA ) function hypothesize contribute neurobiology Major Depressive Disorder ( MDD ) insomnia . The principal objective project use magnetic resonance spectroscopy ( MRS ) provide first vivo characterization cortical GABA level individual primary insomnia , determine whether subject MDD , achieve partial response selective serotonin reuptake inhibitor treatment still experience significant residual symptom include insomnia , altered level neurotransmitter . The investigator also explore correlation cortical AANt level abnormality sleep parameter primary insomnia residual symptom major depression .</brief_summary>
	<brief_title>Cortical GABA Concentrations Insomnia</brief_title>
	<detailed_description>Three group subject ( MDD partial remission residual insomnia , primary insomnia , healthy ) participate study . All subject complete telephone screening , appropriate complete face-to-face evaluation , determine eligibility study . All subject meet eligibility criterion study complete baseline MRS session evaluate difference GABA concentration three group .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Patient Sample . Healthy subject without insomnia ( Group A ) ( n=10 ) Subjects primary insomnia ( Group B ) ( n=20 ) Subjects history major depressive disorder currently partial remission residual insomnia ( Group C ) ( n=20 ) Inclusion Criteria Primary Insomnia Subjects : Males female age 25 55 year Clinical diagnosis primary insomnia meeting DSMIV criterion . Current insomnia rating ( current Sleep Onset Latency SOL &gt; 30 minute , Insomnia Severity Index ( ISI ) &gt; 14 , total sleep time ( TST ) &lt; 6.5 hrs/night ) . No lifetime history psychopathology primary insomnia . No sleep disorder previously identify related condition include sleep disorder breathing , restless leg syndrome , periodic limb movement disorder , chronic pain , gastroesophageal reflux disease , sleep paralysis , nocturnal seizure , nocturia , enuresis ; also narcolepsy REM behavior disorder ( assessed clinical interview Harvard Center Cognition Habitual Sleep Survey ) . Inclusion Criteria Depressed Subjects : Males female age 25 55 year Clinical diagnosis major depression meeting DSMIV criterion partial remission ( HDRS817 ) , confirm semistructured interview SCID HDRS . On monotherapy single SSRI medication period least 6weeks . Remaining symptom insomnia ( current Sleep Onset Latency ( SOL ) &gt; 30 minute , Insomnia Severity Index ( ISI ) &gt; 14 , TST &lt; 6.5 hrs/night ) . Participation judge clinically appropriate treatment team . No sleep disorder previously identify related condition include sleep disorder breathing , restless leg syndrome , periodic limb movement disorder , chronic pain , gastroesophageal reflux disease , sleep paralysis , nocturnal seizure , nocturia , enuresis ; also narcolepsy REM behavior disorder . Inclusion Criteria Healthy Control Subjects : Males female age 25 55 year No lifetime history psychopathology insomnia ( current SOL &lt; 30mins , ISI &lt; 4 , TST &gt; 6.5 hr ) At low risk depression ( e.g. , first degree relative child onset , recurrent , psychotic bipolar depression ) Exclusion Criteria Subjects : History serious medical neurological illness Signs major medical neurological illness examination result laboratory study History psychoactive substance and/or alcohol dependence abuse past 6months . Current use psychoactive medication substance ( exception caffeine , note , use SSRI depressed group ) , two week prior initial scan . More caffeineequivalent 3 cup coffee per day , regular ( i.e. , 1x/2 week ) use caffeine 7pm . Use benzodiazepine olanzapine past 3months . Pregnant nursing Any implant metal devise metal fragment</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>depression</keyword>
	<keyword>GABA</keyword>
	<keyword>magnetic resonance spectroscopy</keyword>
	<keyword>MRS</keyword>
	<keyword>Sleep</keyword>
	<keyword>antidepressant medication use</keyword>
</DOC>